DAMIAN, SILVIA

DAMIAN, SILVIA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 7 di 7 (tempo di esecuzione: 0.015 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 2022 Azzollini, JacopoVingiani, AndreaAgnelli, LucaRosina, EricaDucceschi, MonikaNiger, MonicaDamian, Silviade Braud, FilippoPruneri, Giancarlo + Article (author) -
Targeted RNA-sequencing analysis for fusion transcripts detection in tumor diagnostics: assessment of bioinformatic tools reliability in FFPE samples 2022 Capone I.Verderio P.Busico A.Monti V.Duca M.Damian S.Lorenzini D.Vingiani A.Agnelli L.Pruneri G. + Article (author) -
Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study 2022 Corradini, PaoloMantovani, AlbertoMarasco, VincenzoDamian, SilviaRescigno, Maria + Article (author) -
Nomogram to predict the outcomes of patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors 2021 Pietrantonio, FilippoCorti, FrancescaInfante, GabrieleCurigliano, GiuseppeAmbrosini, MargheritaDamian, Silvia + Article (author) -
Single Institution trial of anthracycline- and taxane-based chemotherapy for operable breast cancer: The ASTER study 2019 Mariani GGalli GCavalieri SDamian SDuca Mde Braud F + Article (author) -
Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib : combined results from two phase I trials (ALKA-372-001 and STARTRK-1) 2017 S. SienaG. CereaG. MarrapeseA. Sartore-BianchiA. VanzulliS. DamianM. DucaF. G. De Braud + Article (author) -
Is a dexamethasone-sparing strategy capable of preventing acute and delayed emesis caused by combined doxorubicin and paclitaxel for breast cancer? : Analysis of a phase II trial 2013 S. DamianE. De BenedictisF. AgustoniF. RicchiniF. De Braud + Article (author) -